ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Ophthalmology

Top Ophthalmology Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
THOMAS DIETZE M.D.

Ophthalmology

9,617

$673K

1742
1569 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

67%
prescriptions for brand name drugs

Avg: 64%

$70
Average prescription price

Avg: $80

ROBERTO ARGUELLO M.D.

Ophthalmology

7,603

$648K

1187
1078 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

68%
prescriptions for brand name drugs

Avg: 64%

$85
Average prescription price

Avg: $80

BRIAN FLOWERS M.D.

Ophthalmology

7,395

$376K

1025
957 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

44%
prescriptions for brand name drugs

Avg: 64%

$51
Average prescription price

Avg: $80

NHU NGUYEN M.D.

Ophthalmology

7,393

$859K

765
699 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

85%
prescriptions for brand name drugs

Avg: 64%

$116
Average prescription price

Avg: $80

KEVIN JONG M.D.

Ophthalmology

6,861

$420K

1193
1082 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

61%
prescriptions for brand name drugs

Avg: 64%

$61
Average prescription price

Avg: $80

ZUHAIR SHIHAB MD

Ophthalmology

6,702

$401K

808
749 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

52%
prescriptions for brand name drugs

Avg: 64%

$60
Average prescription price

Avg: $80

JOHN SOHOCKI M.D.

Ophthalmology

6,595

$396K

1566
1391 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

63%
prescriptions for brand name drugs

Avg: 64%

$60
Average prescription price

Avg: $80

JOHN NICOLAU M.D.

Ophthalmology

6,595

$517K

1074
984 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

72%
prescriptions for brand name drugs

Avg: 64%

$78
Average prescription price

Avg: $80

MARK GALLARDO M.D.

Ophthalmology

6,448

$623K

973
848 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

66%
prescriptions for brand name drugs

Avg: 64%

$97
Average prescription price

Avg: $80

DEBORAH ALEXANDER M.D.

Ophthalmology

6,243

$592K

1059
961 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

69%
prescriptions for brand name drugs

Avg: 64%

$95
Average prescription price

Avg: $80

JASON ZHAO M.D.

Ophthalmology

5,461

$447K

1185
1105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

75%
prescriptions for brand name drugs

Avg: 64%

$82
Average prescription price

Avg: $80

DAVID GODFREY MD

Ophthalmology

5,319

$339K

756
680 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

54%
prescriptions for brand name drugs

Avg: 64%

$64
Average prescription price

Avg: $80

LINDA BURK MD

Ophthalmology

5,240

$345K

1140
994 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

60%
prescriptions for brand name drugs

Avg: 64%

$66
Average prescription price

Avg: $80

RONALD FELLMAN MD

Ophthalmology

5,071

$349K

936
855 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

57%
prescriptions for brand name drugs

Avg: 64%

$69
Average prescription price

Avg: $80

AMBER DOBLER-DIXON M.D.

Ophthalmology

4,933

$544K

717
644 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

83%
prescriptions for brand name drugs

Avg: 64%

$110
Average prescription price

Avg: $80

BRIAN RANELLE D.O.

Ophthalmology

4,828

$408K

1048
968 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

78%
prescriptions for brand name drugs

Avg: 64%

$85
Average prescription price

Avg: $80

LISA MARTEN

Ophthalmology

4,816

$521K

1220
1094 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

71%
prescriptions for brand name drugs

Avg: 64%

$108
Average prescription price

Avg: $80

GLEN BRINDLEY M.D.

Ophthalmology

4,816

$292K

722
661 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

38%
prescriptions for brand name drugs

Avg: 64%

$61
Average prescription price

Avg: $80

FIAZ ZAMAN M.D.

Ophthalmology

4,768

$560K

721
630 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

84%
prescriptions for brand name drugs

Avg: 64%

$117
Average prescription price

Avg: $80

PRAJAY DHIR MD

Ophthalmology

4,767

$411K

795
715 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

69%
prescriptions for brand name drugs

Avg: 64%

$86
Average prescription price

Avg: $80

JOHN DUGAN MD FAAO PA

Ophthalmology

4,669

$170K

971
822 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

43%
prescriptions for brand name drugs

Avg: 64%

$36
Average prescription price

Avg: $80

NEHAL PATEL M.D.

Ophthalmology

4,659

$290K

807
673 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

55%
prescriptions for brand name drugs

Avg: 64%

$62
Average prescription price

Avg: $80

ADAM DOSSEY M. D.

Ophthalmology

4,471

$382K

719
626 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

63%
prescriptions for brand name drugs

Avg: 64%

$85
Average prescription price

Avg: $80

DANIEL GOLDMAN M.D.

Ophthalmology

4,467

$249K

1006
912 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

57%
prescriptions for brand name drugs

Avg: 64%

$56
Average prescription price

Avg: $80

DAVID ABRAMS MD

Ophthalmology

4,140

$320K

838
712 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

68%
prescriptions for brand name drugs

Avg: 64%

$77
Average prescription price

Avg: $80

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank